Crispina Calsada - Net Worth and Insider Trading

Crispina Calsada Net Worth

The estimated net worth of Crispina Calsada is at least $14,571 dollars as of 2024-04-29. Crispina Calsada is the CFO of Regulus Therapeutics Inc and owns about 5,782 shares of Regulus Therapeutics Inc (RGLS) stock worth over $14,571. Details can be seen in Crispina Calsada's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Crispina Calsada has not made any transactions after 2024-01-18 and currently still holds the listed stock(s).

Transaction Summary of Crispina Calsada

To

Crispina Calsada Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Crispina Calsada owns 1 companies in total, including Regulus Therapeutics Inc (RGLS) .

Click here to see the complete history of Crispina Calsada’s form 4 insider trades.

Insider Ownership Summary of Crispina Calsada

Ticker Comapny Transaction Date Type of Owner
RGLS Regulus Therapeutics Inc 2024-01-18 Chief Financial Officer

Crispina Calsada Latest Holdings Summary

Crispina Calsada currently owns a total of 1 stock. Crispina Calsada owns 5,782 shares of Regulus Therapeutics Inc (RGLS) as of January 18, 2024, with a value of $14,571.

Latest Holdings of Crispina Calsada

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RGLS Regulus Therapeutics Inc 2024-01-18 5,782 2.52 14,571

Holding Weightings of Crispina Calsada


Crispina Calsada Form 4 Trading Tracker

According to the SEC Form 4 filings, Crispina Calsada has made a total of 1 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Regulus Therapeutics Inc is the sale of 5,468 shares on January 18, 2024, which brought Crispina Calsada around $6,507.

Insider Trading History of Crispina Calsada

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Crispina Calsada Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Crispina Calsada Ownership Network

Ownership Network List of Crispina Calsada

No Data

Ownership Network Relation of Crispina Calsada


Crispina Calsada Owned Company Details

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Crispina Calsada is the Chief Financial Officer of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and President & Head of R & D Preston Klassen .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Crispina Calsada made 1 insider transaction in Regulus Therapeutics Inc (RGLS) with a net sale of 5,468. Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker ,

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regulus Therapeutics Inc Insider Transactions

No Available Data

Crispina Calsada Mailing Address

Above is the net worth, insider trading, and ownership report for Crispina Calsada. You might contact Crispina Calsada via mailing address: C/o Ambrx, Inc., 10975 N. Torrey Pines Rd., La Jolla Ca 92037.

Discussions on Crispina Calsada

No discussions yet.